This brand name is authorized in Nigeria.
The drug LODIVASC contains one active pharmaceutical ingredient (API):
1
|
UNII
864V2Q084H - AMLODIPINE BESYLATE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-1804 | Tablet | LODIVASC TABLET TAB 5 mg 110,1010 | 32 CMS-PP-336925 LODIVASC TABLET AMLODIPINE 5MG Amlodipine Besylate 6.94mg Pre-gelatinized Starch 25mg Vivasol GF 9.44mg Dicalcium Phosphate 65mg Magnesium Stearate 5.13mg Aerosil 200 2.50mg MCC (102) 116mg A4-1804 Drugs Nigerian Products 110,1010 POM 1 6/20/2023 MAY & BAKER NIGERIA PLC, SAPARA STREET, INDUSTRIAL ESTATE, IKEJA LAGOS LAGOS 18980079 tooluwasanmi@gmail.com May & Baker Nigeria Plc., 1 MAY & BAKER AVENUE, OTA OGUN STATE, Nigeria | 28/09/2023 |
| A4-1805 | Tablet | LODIVASC TABLETS TAB 10 mg 110,1010 | 31 CMS-PP-336921 LODIVASC TABLETS AMLODIPINE BESYLATE 10MG Amlodipine Besylate 13.87mg Pre-gelatinized Starch 25mg Vivasol GF 7.50mg Dicalcium Phosphate 60mg Magnesium Stearate 5.13mg Aerosil 200 2.50mg MCC (102) 116mg A4-1805 Drugs Nigerian Products 110,1010 POM 1 6/20/2023 MAY & BAKER NIGERIA PLC, SAPARA STREET, INDUSTRIAL ESTATE, IKEJA LAGOS LAGOS 18980079 tooluwasanmi@gmail.com May and Baker Nigeria PLC, 1 May & Baker Avenue Idiroko (opp convenant university )Ota Ogun State. P.M.B 21049, Nigeria | 28/09/2023 |
| A4-5280 | Tablet | Lodivasc-10 Tablets TAB 10 mg | 21/12/2020 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C08CA01 | Amlodipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-1804, A4-1805, A4-5280 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.